Scholars Central

Conference abstractPublished 9 Aug 2021

Cold air plasma - A systemic selective adaptogen

Authors: Deborah Black, Mark Edwards, Keryn Johnson, Kostya (Ken) Ostrikov, Erik (Rik) Thompson

Bionic Air Pty Ltd, Gold Coast, Queensland, Australia; Asia Pacific Cell Technology, New South Wales Australia; Quantum Technologies Limited, Wellington, New Zealand Faculty of Science, Queensland; University & Technology, Brisbane Queensland Australia Faculty of Health, Queensland; University & Technology, Brisbane Queensland Australia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This mature plasma medicine device uses corona like cold air plasma technology, which has been designed for safe domestic and hospital use. It is the only one of its kind globally, first invented in 1967 by Australian Citizen Scientist Mr Joshua Shaw and enhanced by his protégé Deborah Black. Pulsed electrical fields of reactive and non-reactive, neutral and negatively charged air ion species are emitted through proprietary quantum portals with variable dosages of power and controlled frequencies which are fully regulated according to the health condition, and other variable factors of the patient for systemic biological benefits. Vibrating emissions and the proprietary safe electrical and magnetic fields created, primarily interact with the respiratory system enhancing immune responses of phagocytes, ameliorating the REDOX biology of the body and neurohormonal disturbances in a naturally selective manner, whilst working as a ‘systematic selective adaptogen®’ for the entire human body systems. The device has also been used for chronic wound healing in diabetic feet plus breast and other cancers. The special air species are both ingestible and transdermal. In Australia, this medical device is TGA registered and has had a long successful market history, reputation and process of Research & Development in humans over 53 years. It is medically registered in Australia and the UK for the treatment and prevention of virus, bacteria and other pathogen related respiratory conditions including colds and flu, allergies, hormones, chronic fatigue, depression, immune system recovery, assist medicine and vitamin absorption plus an array of additional medically allowable claims. Claims which were registered upon the support of safe results, no adverse health events and no recalls in human use. The purpose of this presentation is to show the many and varied impressive and safe results achieved in over 1 Million humans, in an effort to increase global collaboration efforts and scientific knowledge of its unique active mechanisms with modern science for the benefits of all humanity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in International Journal of Biomedical Data Mining.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Biomedical Data Mining
  • SubjectMathematics & Statistics
  • BylineArticles whose byline prints “Deborah Black”
  • BylineArticles whose byline prints “Mark Edwards”
  • BylineArticles whose byline prints “Keryn Johnson”
  • BylineArticles whose byline prints “Kostya (Ken) Ostrikov”
  • BylineArticles whose byline prints “Erik (Rik) Thompson”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels